Epitel
Summary active Updated Jul 30, 2026This profile is AI-generated. If you spot an error, please help us fix it by sharing a URL to the correct information.
About
Epitel develops the REMI Remote EEG Monitoring System, a wireless EEG platform that enables extended-duration monitoring of brain activity at home, integrated with AI-driven event detection to flag potential seizures 123. The platform is cleared for neurological monitoring in patients as young as one year old, with AI-assisted event detection available for patients aged six and older 1. Steve Pacelli serves as President & CEO 1.
Funding History
| Date | Round | Amount | Lead | Co-investors |
|---|---|---|---|---|
| 2026-07-28 | Series B | $26M | Catalyst Health Ventures, Genoa Ventures | 123 |
Proceeds will fund sales and marketing team growth, deployment infrastructure at hospitals and clinics, and expanded access to ambulatory at-home monitoring 12.
What Investors Say
No independently sourced investor commentary beyond press-release attribution at this time.
What Founders Say
No independently sourced founder quotes available at this time.
Sources
-
Yahoo Finance / Epitel press release, “Epitel Secures $26 Million Series B to Expand Remote Wireless EEG Monitoring,” July 28, 2026. Accessed July 2026. https://finance.yahoo.com/healthcare/articles/epitel-secures-26-million-series-100000611.html↩↩↩↩↩
-
Utah Business, “Epitel raises $26M to expand wireless EEG monitoring and seizure detection,” July 28, 2026. Accessed July 2026. https://www.utahbusiness.com/industry/2026/07/28/epitel-raises-26-million-expand-wireless-eeg-monitoring-health-series-b/↩↩↩
-
BioWorld, “Epitel raises $26M for wireless EEG system for seizure monitoring,” July 2026. Accessed July 2026. https://www.bioworld.com/articles/732930-epitel-raises-26m-for-wireless-eeg-system-for-seizure-monitoring↩↩